Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the <scp>JAK</scp>‐<scp>STAT</scp> pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
Haneen Nur(Hebron University), Eline Menu(Vrije Universiteit Brussel)
Cited by 14
Related Papers
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
|Oncotarget|2015|147
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
|Journal of Experimental & Clinical Cancer Research|2022|31
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis
|The Journal of Pathology|2023|28
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma
|Haematologica|2023|11
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
|Journal of Hematology & Oncology|2025|4